KNSA Earnings

Quarterly EPS
$-0.18
Q3 2024
$-0.12
Q4 2024
$0.12
Q1 2025
$0.24
Q2 2025
$0.25
Q3 2025
$0.19
Q4 2025
$0.30
Q1 2026
$0.33
Q2 2026
Latest Revenue243.6M
Latest Net Income25.4M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.33243.6M25.4M+55.4%+37.5%
Q1 2026$0.30214.3M22.6M+55.5%+150.0%
Q4 2025$0.19202.1M14.2M+65.0%+258.3%
Q3 2025$0.25180.9M18.4M+61.2%+238.9%
Q2 2025$0.24156.8M17.8M+44.3%+500.0%
Q1 2025$0.12137.8M8.5M+72.5%+148.0%
Q4 2024-$0.12122.5M-8888000+46.9%-133.3%
Q3 2024-$0.18112.2M-12693000+67.4%+10.0%
Q2 2024-$0.06108.6M-3908000
Q1 2024-$0.2579.9M-17704000
Q4 2023$0.3683.4M25.2M
Q3 2023-$0.2067.0M-13855000
Kiniksa Pharmaceuticals International (KNSA) — Earnings